[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: year 15, Issue 61 (12-2023) ::
3 2023, 15(61): 13-20 Back to browse issues page
A review on the latest clinical and laboratory criteria for diagnosis of the Sjogren’s syndrome
Sedigheh Sharifzadeh 1, Fatemeh Nasri1
1- Shiraz University of Medical Sciences, School of Paramedical Sciences
Abstract:   (507 Views)
Sjogren's syndrome (SS) is a chronic progressive autoimmune disease that is usually followed by rheumatologists. Delayed diagnosis of the disease is common because the symptoms of the disease are non-specific and the disease progresses slowly.
SS is characterized by dry eyes and mouth, although a wide range of symptoms such as joint pain, skin rashes, chronic dry cough, vaginal dryness, numbness in the extremities, and excruciating fatigue are also included.
The common diagnostic criteria proposed by the American/European Society of Rheumatology in 2016 (2016 ACR/EULAR) can help in the diagnosis of SS. These criteria include clinical symptoms, positive serology tests, and biopsy findings of salivary glands. Common biomarkers used for SS disease include anti-SS-A/Ro, ANA, anti SS-B/La and RF. While these biomarkers are useful for diagnosing the disease, they are not always positive, especially in the early stage of the disease, and importantly, they are not specific for SS disease. Several biomarkers specific to salivary-lacrimal glands have been recently introduced, including SP-1 (salivary gland prolein-1) (parotid secretory protein) PSP and (carbonic anhydrase) CA-6.
Studies show that these new biomarkers are very important in the early diagnosis of the disease. For this reason, the researchers designed a test called SjO diagnostic test, which is commercially available to diagnose SS disease, and in this test, common biomarkers (anti-SS-A/RO, anti-SS-B/LO, ANA and RF) and new biomarkers (antibodies to SP -1, PSP and CA-6) are evaluated. This test increases the sensitivity and specificity of SS diagnosis. Timely diagnosis of SS disease requires the cooperation of rheumatologists, ophthalmologists and dentists and the correct selection of differential work-up, which includes physical and clinical evaluations.

 
Keywords: Sjogren syndrome, anti-SS-A/La, anti-SS-B/Ro, anti-SP-1, anti-PSP, anti-CA-6, SjO test
Full-Text [PDF 976 kb]   (333 Downloads)    
Type of Study: Review | Subject: ایمنی شناسی (ایمونولوژی)
Received: 2023/12/23 | Accepted: 2023/12/23 | Published: 2023/12/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifzadeh S, Nasri F. A review on the latest clinical and laboratory criteria for diagnosis of the Sjogren’s syndrome. 3 2023; 15 (61) :13-20
URL: http://labdiagnosis.ir/article-1-550-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 15, Issue 61 (12-2023) Back to browse issues page
Laboratory and Diagnosis
Persian site map - English site map - Created in 0.06 seconds with 36 queries by YEKTAWEB 4645